πŸ‡ΊπŸ‡Έ FDA
Patent

US 11814376

Hepatitis b core protein modulators

granted A61KA61K31/554A61K45/06

Quick answer

US patent 11814376 (Hepatitis b core protein modulators) held by ASSEMBLY BIOSCIENCES, INC. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ASSEMBLY BIOSCIENCES, INC.
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/554, A61K45/06, A61P, A61P31/20